I don’t have live access to tools right now, but I can share the latest general context on gene knockout news up to my last update and how to find current developments.
Direct answer
- The field continues to advance with human knockout studies informing drug targets and safety profiles, but for the very latest headlines you’ll want to check current science news sources and major journals.
What to look for in the latest news
- Human knockout studies: reports on naturally occurring loss-of-function variants and their clinical phenotypes, used to identify potential drug targets and tolerability concerns.
- CRISPR and gene-editing trials: updates on therapeutic knockouts in cells, animal models, or human trials, including safety and efficacy signals.
- Large-scale projects: news from initiatives like the Human Knockout Project or similar consortia tracking gene essentiality and disease associations.
- Drug development implications: articles discussing how knockout data influence target selection, patient stratification, and anticipated side effects.
Where to find reliable recent coverage
- Major science journals and news sites: Science, Nature, Cell, and their news sections for breakthrough reports.
- Genomics and biotechnology outlets: GenomeWeb, STAT, BioTechniques, and institutional press rooms (Broad Institute, NIH, university press offices).
- Public health and policy context: FDA/EMA updates on gene-targeted therapies and safety monitoring.
Illustrative example
- A representative story would describe a gene knockout in humans revealing that loss of function for a given gene is tolerated or leads to specific phenotypes, which in turn points toward a possible therapeutic target or flags potential adverse effects to monitor in trials. This pattern has been cited as a way to de-risk drug discovery by leveraging natural human variation.[5]
If you’d like, I can search for the very latest headlines on “gene knockout” across reputable sources and summarize the top three to five stories with quick takeaways. I can also tailor recommendations to a specific subfield (e.g., cancer, metabolic disease, neurological disorders).
Sources
Naturally occurring human genetic variants provide “experiments of nature” that can directly inform on the function of human genes. In addition to providing novel insight into human biology, they can aid in the identification and validation of genes that would be powerful and well-tolerated targets for therapeutic inhibition in both rare and common diseases.
www.broadinstitute.orgBroad Institute is a multidisciplinary community of researchers on a mission to improve human health.
www.broadinstitute.orgSome people are naturally missing the working copy of a gene, the result of which can range from no effect at all to, occasionally, profound effects, such as very low cholesterol or congenital insensitivity to pain. Such significant, unusual medical characteristics are commonly referred to as “extreme phenotypes.” These extreme phenotypes and their underlying genetic causes represent, in a sense, experiments of nature that point the way toward a new understanding of disease, and potentially...
www.pfizer.comEDITGENE provides various cell lines gene editing services and related products, such as CRISPR library screening, knockout cell line, Knock in cell line, point mutation cell line Cas12a, etc.
www.editxor.comThe total loss of protein-coding genes, even those with the potential to confer genetic diseases, can be tolerated.
www.science.orgExplore in-depth articles on CRISPR gene editing, including literature reviews, emerging research frontiers, and key scientific insights.
www.editxor.com